156 related articles for article (PubMed ID: 2553090)
1. Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.
Thatcher N; Lind M; Stout R; Payne C; Carroll KB; Campbell C; Moussalli H
Br J Cancer; 1989 Jul; 60(1):98-101. PubMed ID: 2553090
[TBL] [Abstract][Full Text] [Related]
2. Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
Prendiville J; Radford J; Thatcher N; Steward W; Ranson M; Burt P; Stout R
J Clin Oncol; 1991 Aug; 9(8):1446-52. PubMed ID: 1649266
[TBL] [Abstract][Full Text] [Related]
3. Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation.
Prendiville J; Lorigan P; Hicks F; Leahy B; Stout R; Burt P; Thatcher N
Eur J Cancer; 1994; 30A(14):2085-90. PubMed ID: 7857708
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Smith IE; Perren TJ; Ashley SA; Woodiwiss J; Forgeson GV; Yarnold JR; Ford HT
J Clin Oncol; 1990 May; 8(5):899-905. PubMed ID: 2159056
[TBL] [Abstract][Full Text] [Related]
5. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K
Cancer Chemother Pharmacol; 1990; 25(5):367-70. PubMed ID: 2155064
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin in small cell lung cancer.
Thatcher N; Lind M
Semin Oncol; 1990 Feb; 17(1 Suppl 2):40-8. PubMed ID: 2154859
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
9. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
10. Intensive combined-modality therapy in small cell lung cancer.
Thatcher N; Lorrigan P; Burt P; Stout R
Semin Oncol; 1994 Jun; 21(3 Suppl 6):9-22. PubMed ID: 8052879
[TBL] [Abstract][Full Text] [Related]
11. Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.
Hanauske AR; Korfel A; Perker M; Heinrich B; Schwab G; Graf M; Depenbrock H; Höffken G; Kreuser ED; Thiel E; Zwingers T; Berdel WE
Oncology; 1997; 54(5):363-70. PubMed ID: 9260596
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study.
Ruotsalainen T; Halme M; Isokangas OP; Pyrhönen S; Mäntylä M; Pekonen M; Sarna S; Joensuu H; Mattson K
Anticancer Drugs; 2000 Feb; 11(2):101-8. PubMed ID: 10789592
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.
Bishop JF; Raghavan D; Stuart-Harris R; Morstyn G; Aroney R; Kefford R; Yuen K; Lee J; Gianoutsos P; Olver IN
J Clin Oncol; 1987 Oct; 5(10):1574-8. PubMed ID: 2821197
[TBL] [Abstract][Full Text] [Related]
16. [Combined alternating radiochemotherapy in stage III (TNM) (limited disease) small cell bronchial carcinoma: a phase II study with carboplatin/etoposide/vincristine and alternating radiotherapy].
Serke M; Riedel U; Schönfeld N; Pannhorst J; Förster B; Loddenkemper R
Pneumologie; 1999 Oct; 53(10):485-92. PubMed ID: 10596551
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
Glisson B; Scott C; Komaki R; Movsas B; Wagner H
J Clin Oncol; 2000 Aug; 18(16):2990-5. PubMed ID: 10944132
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study.
Virén M; Liippo K; Ojala A; Helle L; Jakobson M; Järvinen M; Paloheimo S; Salomaa ER; Salmi R; Nikkanen V
Acta Oncol; 1992; 31(7):761-5. PubMed ID: 1335738
[TBL] [Abstract][Full Text] [Related]
19. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
Bleehen NM; Girling DJ; Machin D; Stephens RJ
Br J Cancer; 1993 Dec; 68(6):1150-6. PubMed ID: 8260367
[TBL] [Abstract][Full Text] [Related]
20. Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clinique de l'Université Catholique de Louvain, Brussels and Liège, Belgium.
van de Velde H; Bosquée L; Weynants P; Canon JL; Rosier JF; Humblet Y
Ann Oncol; 1999 Sep; 10(9):1051-7. PubMed ID: 10572602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
